# Milrinone for Prevention of Post-ligation Cardiac Syndrome Trial

> **NCT06679855** · PHASE3 · RECRUITING · sponsor: **NICHD Neonatal Research Network** · enrollment: 316 (estimated)

## Conditions studied

- Post-ligation Cardiac Syndrome

## Interventions

- **DRUG:** Milrinone infusion
- **DRUG:** Placebo infusion

## Key facts

- **NCT ID:** NCT06679855
- **Lead sponsor:** NICHD Neonatal Research Network
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-13
- **Primary completion:** 2027-06-30
- **Final completion:** 2029-06-30
- **Target enrollment:** 316 (ESTIMATED)
- **Last updated:** 2026-04-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06679855

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06679855, "Milrinone for Prevention of Post-ligation Cardiac Syndrome Trial". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06679855. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*